Welcome to HCC-TAG! Our mission is to bring the latest updates in
therapeutic developments in HCC from leading researchers in the field in an
interactive, multidisciplinary format. Our directors and scientific advisory board members are experts in the field of HCC within the fields of hepatology, surgery, oncology and interventional oncology, and more.

The purpose of our conference is to bring together clinicians and researchers in academia and the pharmaceutical industry for a focused educational update to highlight the most relevant advances and challenges in the diagnosis and therapy of HCC. This single topic conference will take place over two days in Park City, Utah, providing attendees with an understanding of current and future directions in the HCC treatment landscape as well as prospects and challenges in drug discovery and development for HCC. Nationally and internationally renowned faculty will assist in the development of the educational content and will serve as faculty at the conference.

Sincerely,
Anjana Pillai, MD
Associate Professor of Medicine
University of Chicago Medicine

Michael Charlton, MD
Professor of Medicine
University of Chicago Medicine